How COVID-19 Will Accelerate A Digital Therapeutics Revolution
Reimagining medtech for a COVID-19 world | McKinsey #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance
27/04/2020
28 companies, including tech firms, collaborate on EHR-fueled COVID-19 database
27/04/2020
The principal beneficiary of the digital therapeutics revolution will be the patients that use them. Although it has taken a tragedy like COVID-19 to spur these changes, if the positive ones remain, it will lead to more options, lower prices, and greater access to innovative treatments.
Source: www.forbes.com
